KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 6,140.00
+210.00 (3.54%)
At close: Sep 15, 2025
KoBioLabs Revenue
KoBioLabs had revenue of 17.61B KRW in the quarter ending June 30, 2025, a decrease of -6.86%. This brings the company's revenue in the last twelve months to 69.48B, up 33.41% year-over-year. In the year 2024, KoBioLabs had annual revenue of 68.36B with 106.28% growth.
Revenue (ttm)
69.48B
Revenue Growth
+33.41%
P/S Ratio
1.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
119.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68.36B | 35.22B | 106.28% |
| Dec 31, 2023 | 33.14B | 21.53B | 185.54% |
| Dec 31, 2022 | 11.61B | 8.71B | 301.12% |
| Dec 31, 2021 | 2.89B | -1.70B | -36.98% |
| Dec 31, 2020 | 4.59B | 4.01B | 696.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |